Whilst animal studies raised concerns about thyroid tumours, these findings have not been replicated in human populations over follow-up periods of 25 years
The identification of ferroptosis in disease models is increasingly recognized as a key research direction for elucidating disease mechanisms and developing novel therapeutic strategies
GLP-1 BENEFITS Do more, age less GLP-1s mimics glucagon-like peptide (GLP-1), a hormone that regulates appetite and food intake
Older adults, those with liver disease, alcohol use, malnutrition, CYP2E1 genetic variations, and users of other hepatotoxic drugs face higher depletion risk
For instance, when intra-portal insulin levels are increased [e.g., obesity, Cushings syndrome or due to treatment with glucocorticoids and glucagon-like peptide-1 receptor agonists (GLP-1RA)] or decreased (e.g., anorexia nervosa and T1D) in disease states, these secondary changes (secondary association) alters hepatic GH sensitivity resulting in discordant GH and IGF-I levels (high GH/low IGF-I levels and low GH/high IGF-I levels, respectively)